new molecules and indications for glp-1 medicines The everything drugs: from weight loss to whole body GIPR/GLP-1R dual agonist therapies for

Recognizing warning signs ensures timely intervention and prevents serious complications

Far from being a consequence of poor lifestyle or medication side effects alone, IR has been detected in young, drug-nave, and non-obese psychiatric patients, suggesting it may represent an intrinsic biological vulnerability in affective illness [12,35]

Current GLP-1-based treatments, including exenatide, liraglutide, dulaglutide, semaglutide, and tirzepatide, offer varying pharmacokinetic profiles that allow for once-daily or once-weekly dosing, improving patient adherence

[DOI] [PMC free article] [PubMed] [Google Scholar] Yaqub T, Tikhonova IG, Lttig J, Magnan R, Laval M, Escrieut C, Boulgue C, Hewage C, Fourmy D

This gastroparesis stomach paralysis can be permanent even after you stop taking Ozempic

Think of it as fine-tuning your results, not replacing your effort